Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pneumococcal Vaccine Schedules
ISRCTN15056916Phase 4Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Aug 2019
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Prevnar 13 in pneumococcal disease and Pneumococcal carriage (NPC), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Vaccine-type pneumococcal nasopharyngeal carriage in children with clinical pneumonia. Started Aug 2019; status: completed.
02
Drugs
Prevnar 13
03
Conditions
pneumococcal diseasePneumococcal carriage (NPC)
Beyond the preview
Go deeper on ISRCTN15056916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15056916.